{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T17:14:15Z","timestamp":1792343655473,"version":"4.4.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"am","delay-in-days":348,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["C06 CA059267"],"award-info":[{"award-number":["C06 CA059267"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA006516"],"award-info":[{"award-number":["P30CA006516"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","redjournal.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.ijrobp.2024.12.034","type":"journal-article","created":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T00:33:36Z","timestamp":1736555616000},"page":"52-62","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Long-term Outcomes of Definitive Chemoradiation With Proton Therapy for Treatment of Carcinoma of the Anal Canal: Combined Analysis of Two Prospective Trials"],"prefix":"10.1016","volume":"122","author":[{"given":"Grace","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bailey","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Koenig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P.","family":"Plastaras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Metz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beow Y.","family":"Yeap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongbin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorraine C.","family":"Drapek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Baglini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David P.","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aparna R.","family":"Parikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill N.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey W.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence S.","family":"Blaszkowsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgar","family":"Ben-Josef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodore S.","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan R.","family":"Kharofa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer Y.","family":"Wo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2024.12.034_bib0001","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1002\/1097-0142(19830515)51:10<1826::AID-CNCR2820511012>3.0.CO;2-L","article-title":"Combined preoperative radiation and chemotherapy for squamous cell carcinoma of the anal canal","volume":"51","author":"Nigro","year":"1983","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2024.12.034_bib0002","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0140-6736(96)03409-5","article-title":"Epidermoid anal cancer: Results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin","volume":"348","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2024.12.034_bib0003","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1001\/jama.299.16.1914","article-title":"Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: A randomized controlled trial","volume":"299","author":"Ajani","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.ijrobp.2024.12.034_bib0004","doi-asserted-by":"crossref","first-page":"4344","DOI":"10.1200\/JCO.2012.43.8085","article-title":"Long-term update of US GI intergroup RTOG 98-11 phase III trial for anal carcinoma: Survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil\/mitomycin versus fluorouracil\/cisplatin","volume":"30","author":"Gunderson","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2024.12.034_bib0005","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ijrobp.2012.09.023","article-title":"RTOG 0529: A phase 2 evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal","volume":"86","author":"Kachnic","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.12.034_bib0006","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ijrobp.2021.08.008","article-title":"Long-term outcomes of NRG oncology\/RTOG 0529: A phase 2 evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in anal canal cancer","volume":"112","author":"Kachnic","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.12.034_bib0007","series-title":"Proton and Charged Particle Radiotherapy","year":"2008"},{"key":"10.1016\/j.ijrobp.2024.12.034_bib0008","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.radonc.2015.10.027","article-title":"Scanning proton beam therapy reduces normal tissue exposure in pelvic radiotherapy for anal cancer","volume":"117","author":"Anand","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2024.12.034_bib0009","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.3109\/0284186X.2014.1002570","article-title":"Pencil-beam scanning proton therapy for anal cancer: A dosimetric comparison with intensity-modulated radiotherapy","volume":"54","author":"Ojerholm","year":"2015","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ijrobp.2024.12.034_bib0010","doi-asserted-by":"crossref","first-page":"11","DOI":"10.14338\/IJPT-17-00017","article-title":"Dosimetric comparison of intensity-modulated proton therapy and volumetric-modulated arc therapy in anal cancer patients and the ability to spare bone marrow","volume":"4","author":"Meier","year":"2017","journal-title":"Int J Part Ther"},{"key":"10.1016\/j.ijrobp.2024.12.034_bib0011","article-title":"Multi-institutional comparison of intensity modulated photon versus proton radiation therapy in the management of squamous cell carcinoma of the anus","volume":"6","author":"Mohiuddin","year":"2021","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2024.12.034_bib0012","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ijrobp.2019.04.040","article-title":"Pencil beam scanning proton beam chemoradiation therapy with 5-Fluorouracil and Mitomycin-C for definitive treatment of carcinoma of the anal canal: a multi-institutional pilot feasibility study","volume":"105","author":"Wo","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.12.034_bib0013","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/COC.0000000000001007","article-title":"Feasibility trial of intensity modulated proton therapy to reduce toxicity in anal cancer patients","volume":"46","author":"Nelson","year":"2023","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2024.12.034_bib0014","unstructured":"U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE) version 4.0. 2010. Available at: https:\/\/ctep.cancer.gov\/protocolDevelopment\/adverse_effects.htm. Accessed July 31, 2024."},{"key":"10.1016\/j.ijrobp.2024.12.034_bib0015","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1016\/j.ejca.2009.08.014","article-title":"Clinical and psychometric validation of the EORTC QLQ-CR29 questionnaire module to assess health-related quality of life in patients with colorectal cancer","volume":"45","author":"Whistance","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijrobp.2024.12.034_bib0016","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1097\/00005650-200110000-00009","article-title":"Symptom indexes to assess outcomes of treatment for early prostate cancer","volume":"39","author":"Clark","year":"2001","journal-title":"Med Care"},{"key":"10.1016\/j.ijrobp.2024.12.034_bib0017","first-page":"119","article-title":"Patient-reported outcomes vs. clinician symptom reporting during chemoradiation for rectal cancer","volume":"5","author":"Flores","year":"2012","journal-title":"Gastrointest Cancer Res"},{"key":"10.1016\/j.ijrobp.2024.12.034_bib0018","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/BF02237236","article-title":"Fecal incontinence quality of life scale: Quality of life instrument for patients with fecal incontinence","volume":"43","author":"Rockwood","year":"2000","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.ijrobp.2024.12.034_bib0019","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1080\/009262300278597","article-title":"The female sexual function index (FSFI): A multidimensional self-report instrument for the assessment of female sexual function","volume":"26","author":"Rosen","year":"2000","journal-title":"J Sex Marital Ther"},{"key":"10.1016\/j.ijrobp.2024.12.034_bib0020","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/S0090-4295(97)00238-0","article-title":"The international index of erectile function (IIEF): A multidimensional scale for assessment of erectile dysfunction","volume":"49","author":"Rosen","year":"1997","journal-title":"Urology"},{"key":"10.1016\/j.ijrobp.2024.12.034_bib0021","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.ijrobp.2023.04.023","article-title":"Long-term patient-reported quality of life of anal cancer survivors treated with intensity modulated radiation therapy and concurrent chemotherapy: Results from a prospective phase II trial","volume":"117","author":"Joseph","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.12.034_bib0022","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1016\/j.ijrobp.2021.07.110","article-title":"Long-term patient-reported quality of life and functional outcomes after chemoradiation using intensity modulated radiotherapy for anal cancer","volume":"111","author":"De","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.12.034_bib0023","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.ijrobp.2006.06.041","article-title":"Accelerated partial-breast irradiation using proton beams: Initial clinical experience","volume":"66","author":"Kozak","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.12.034_bib0024","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1200\/JCO.18.02366","article-title":"Phase II study of proton beam radiation therapy for patients with breast cancer requiring regional nodal irradiation","volume":"37","author":"Jimenez","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2024.12.034_bib0025","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.41538","article-title":"Toxicity profiles and survival outcomes among patients with nonmetastatic oropharyngeal carcinoma treated with intensity-modulated proton therapy vs intensity-modulated radiation therapy","volume":"5","author":"Youssef","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ijrobp.2024.12.034_bib0026","unstructured":"U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE) version 3.0. 2006. Available at: https:\/\/Ctep.Cancer.Gov\/protocolDevelopment\/Adverse_effects.Htm. Accessed July 31, 2024."},{"key":"10.1016\/j.ijrobp.2024.12.034_bib0027","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.ijrobp.2007.06.072","article-title":"Involved-field, low-dose chemoradiotherapy for early-stage anal carcinoma","volume":"70","author":"Hatfield","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.12.034_bib0028","first-page":"591","article-title":"Lower-dose chemoradiation in treating patients with early-stage anal cancer, the DECREASE study","volume":"105","year":"2019","journal-title":"Case Med Res"},{"key":"10.1016\/j.ijrobp.2024.12.034_bib0029","doi-asserted-by":"crossref","first-page":"E164","DOI":"10.1016\/j.ijrobp.2016.06.1006","article-title":"The development of an umbrella trial (PLATO) to address radiation therapy dose questions in the locoregional management of squamous cell carcinoma of the anus","volume":"96","author":"Sebag-Montefiore","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.12.034_bib0030","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.ijrobp.2017.03.022","article-title":"Capecitabine with mitomycin reduces acute hematologic toxicity and treatment delays in patients undergoing definitive chemoradiation using intensity modulated radiation therapy for anal cancer","volume":"98","author":"Goodman","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.12.034_bib0031","doi-asserted-by":"crossref","first-page":"e449","DOI":"10.3747\/co.21.1903","article-title":"One compared with two cycles of mitomycin C in chemoradiotherapy for anal cancer: Analysis of outcomes and toxicity","volume":"21","author":"Yeung","year":"2014","journal-title":"Curr Oncol"},{"key":"10.1016\/j.ijrobp.2024.12.034_bib0032","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1097\/NCC.0b013e318269040f","article-title":"Comparison between patient-reported and clinician-observed symptoms in oncology","volume":"36","author":"Xiao","year":"2013","journal-title":"Cancer Nurs"},{"key":"10.1016\/j.ijrobp.2024.12.034_bib0033","unstructured":"Ume\u00e5 University. Proton versus photon therapy in anal squamous cell carcinoma (SWANCA). Available at: https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT04462042. Accessed August 1, 2024."}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S036030162500015X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S036030162500015X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T12:26:54Z","timestamp":1744633614000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S036030162500015X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S036030162500015X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2024.12.034","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term Outcomes of Definitive Chemoradiation With Proton Therapy for Treatment of Carcinoma of the Anal Canal: Combined Analysis of Two Prospective Trials","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2024.12.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}